Abstract
Subjective and objective assessments were made of 24 vertigenous patients recieving 300mg daily Dilazep Dihydrochloride during a 2 month period. Of the patients included in this study, 7 had vertebro-basilar insufficiency, 14 had Meniere's disease, 2 had vestibular neuronitis and 1 had labyrinthitis. There was no significant difference in improvement rate between subjective and objective assessments. The average improvement rate was 33.3%, based on the excellent and moderately improved groups. The average improvement rate was 83.3%, when the slightly improved group was included. No side effects of this drug were observed among these patients during this test period.
